Biotech & Life Sciences
InspireMD Wins FDA Approval for CGuard Prime in TCAR Procedures
InspireMD (Nasdaq: NSPR) announced November 12 that the FDA approved its premarket approval supplement for the CGuard Prime TransCarotid Stent System, for use in transcarotid artery revascularization (TCAR), a carotid stenting procedure performed through a small incision at the base of the neck instead of through the groin. The company’s prospectus supplement dates the approval to November 9. The system uses an 80 cm delivery catheter and, for now, has to be paired with an existing FDA-cleared embolic protection system specified in its labeling.
Approval rests on the CGUARDIANS II pivotal trial, a single-arm US study of 50 high-surgical-risk patients at 11 sites. At 30 days the company reported 100% acute device success and no deaths, strokes, heart attacks, or stent thrombosis. Fifty patients and one month of follow-up is a thin data set, even if a clean one.
InspireMD estimates more than 35,000 TCAR procedures are performed in the US each year and says the approval doubles the addressable market for CGuard Prime. It also returns the platform to the US market after a May 2026 voluntary recall of the separate 135 cm delivery system used in standard carotid artery stenting, which the company said did not meet performance expectations during a controlled launch. Its proprietary neuroprotection system, SwitchGuard, remains investigational and is enrolling in the CGUARDIANS III pivotal trial.
The money came next. Late on November 12 the company launched an underwritten public offering and priced it the next morning at $37.5 million: 7,342,308 shares, pre-funded warrants for another 50,350,000 shares, and common warrants for 43,269,231 more, with closing expected around November 16. InspireMD had 46,785,131 shares outstanding before the deal, so the new shares and pre-funded warrants together exceed the entire existing share count before a single common warrant is exercised.
The preliminary prospectus supplement lists substantial doubt about the company’s ability to continue as a going concern and discloses a Nasdaq minimum bid price deficiency notice received July 17, with a January 13, 2027 deadline to regain compliance. The stock last traded at $0.80 on November 11. Cash stood at about $19.2 million on September 30, and third-quarter revenue came in at roughly $2.2 million.
Tech & Innovation
Ainos Signs $9 Million ASE Order for 5,000 AI Nose Systems
Ainos (Nasdaq: AIMD) signed a $9 million purchase agreement with ASE Technology Holding, the semiconductor packaging and testing group, for 5,000 additional AI Nose systems, announced November 12. AI Nose pairs gas sensors with machine learning to turn airborne chemical signals into data that helps engineers track chemical conditions and anomalies inside advanced packaging plants. The company calls it the largest order by value in its history, about 4.3 times the $2.1 million agreement under which it delivered 1,400 systems.
The stock, under 50 cents before the release, more than doubled on the session, leaving a market value of roughly $10.7 million at $1.23 per StockTitan.
ASE owes a $4.5 million deposit within 60 days of signing, with the balance due after delivery against shipping documentation. No delivery schedule has been disclosed. For a company that held $1.42 million in cash on June 30, the deposit alone is more than three times its bank balance. Ainos’s second-quarter 10-Q states substantial doubt about its ability to continue as a going concern and shows an accumulated deficit of $74.6 million.
One customer is carrying most of this story. ASE is the buyer, and an ASE affiliate, ASE Test, is also a lender, with $1.94 million of its loan to Ainos maturing July 31, 2027 and another $875,140 due March 27, 2027.
Mining & Minerals
Tudor Gold Hits 9.00 g/t Gold Over 9.50 Meters at Perfectstorm
Tudor Gold (TSXV: TUD, OTC Pink: TDRRF) reported four holes from the Perfectstorm Zone at its 80%-owned Treaty Creek project in BC’s Golden Triangle on November 11. Hole PS-26-36 returned 9.50 meters grading 9.00 g/t gold from 163.50 meters downhole, including 1.20 meters at 43.29 g/t, and separately cut 4.20 meters of 713.91 g/t silver from 45.00 meters. PS-26-34 returned 37.50 meters at 2.25 g/t gold from 127.50 meters. All intervals are drilled lengths; true widths have not been determined.
Those two holes sit about 500 meters northwest of earlier Perfectstorm porphyry drilling and define what the company describes as a new high-grade low to intermediate sulfidation system, a vein-style gold-silver deposit type that forms at shallow depths. Mineralization runs along 125 meters of strike so far, and PS-26-34 caught it 190 meters down-dip of where it reaches surface.
Drilling is done for the year: 22,511 meters in 44 holes, with 19 holes still at the lab, including PS-26-37 and PS-26-38, which were aimed at the new northwest zone. Tudor plans a maiden resource for the Perfectstorm area once those assays are in but has given no date, and Perfectstorm currently contributes nothing to the project’s resource. The larger pending item is the Goldstorm PEA, which management had targeted for summer 2026 and which was still listed as open in October.
Surface select samples ran as high as 35.66 g/t gold, though the company cautions select samples may not represent true grades. TDRRF is quoted on OTC Pink, a limited-disclosure tier, so US investors should check with their broker on availability before trading.
Green Energy & Cleantech
Turbo Energy Adds $7.6 Million in Pamesa Battery Storage Orders

Turbo Energy (Nasdaq: TURB) booked additional orders worth €6.83 million, about US$7.62 million, to expand its role in Pamesa Net Zero, the industrial energy program at the Spanish factories of ceramic tile maker Pamesa Group, announced November 10. The orders add a net 51 MWh of contracted battery storage across two new industrial sites and capacity increases at existing ones, covering storage systems, inverters, Turbo’s AI-driven energy management software, and integration work.
Phase II sits on top of the roughly $53 million contract for 366 MWh across 10 factories that Turbo signed in September 2025, of which 62.5 MWh was running at three sites as of October. Equipment deliveries for the new orders are expected in the first half of 2027. The company’s Form 6-K describes the figure as additional contracted business attributable to Turbo, so revenue from this week’s headline depends on shipments that are still quarters away.
Phase II also deepens Turbo’s reliance on a single industrial customer group.
Nasdaq flagged Turbo in January for falling below the $2.5 million stockholders’ equity minimum. The company regained compliance in June after raising about $5 million through a registered direct offering and its at-the-market program, and Nasdaq warned at the time that failing to show compliance in its next periodic report could subject it to delisting.
Crypto & Fintech: What Moved the Sector This Week
Bitcoin traded near $75,750 on November 7 and fell to about $65,000 by Saturday morning, November 14, a decline of roughly 14% and its weakest level since mid-August. Most of the cited pressure came from rates: the 10-year Treasury yield closed at 5.15% on Friday, the dollar index held at a 19-month high, and futures traders priced in a quarter-point hike at the Fed’s December 8 to 9 meeting.
US spot bitcoin ETFs extended a run of daily outflows, with about $1.07 billion leaving over the week, and $637 million in leveraged positions were liquidated in one 24-hour stretch, 91% of them longs. After the US close on November 11, MSCI said it will remove Strategy, Metaplanet, and Upexi from its indexes at the close of November 30, on the view that bitcoin and token treasury companies look more like investment funds than operating businesses. Mining difficulty fell 9.1% on Saturday, the largest cut since June.
No small or micro-cap crypto or fintech equity on the TSX, TSXV, CSE, or US exchanges produced company-specific news strong enough to stand on its own; the move played out at the token, ETF, and large-cap treasury level.
What to Watch Next
The company has not given a launch date. Near-term markers are the offering’s expected close around November 16, two CGuard talks at the VEITH symposium November 17 to 21, a planned December PMA supplement for an improved CGuard Prime delivery system for standard carotid stenting, and the January 13, 2027 deadline to regain compliance with Nasdaq’s $1 minimum bid price rule.
The deposit is due within 60 days of signing, and the balance only after delivery, for which no schedule has been published. Ainos’s next quarterly filing will show its cash position going into the order and whether the going concern language changes.
Nineteen holes from the completed 2026 program are awaiting assays, including PS-26-37 and PS-26-38 into the new northwest zone. A maiden Perfectstorm resource is planned once all assays are in, and the Goldstorm PEA remains the larger outstanding catalyst.
Equipment has to ship, with deliveries expected in the first half of 2027, and be installed at the two new sites and the expanded existing ones. Turbo has not disclosed site-by-site commissioning dates.
As of Friday, futures were pricing a quarter-point hike at the December 8 to 9 meeting. Before that, MSCI’s index deletions take effect at the November 30 close, and daily spot ETF flow data will show whether the outflow streak breaks.
Sources
- InspireMD Announces FDA Approval of the CGuard Prime TransCarotid Stent System for TCAR Procedures, SEC EDGAR (Form 8-K, Exhibit 99.1), November 12, 2026
- InspireMD Reports Third Quarter 2026 Financial Results, SEC EDGAR (Form 8-K, Exhibit 99.1), November 12, 2026
- InspireMD Preliminary Prospectus Supplement, SEC EDGAR (Form 424B5), November 12, 2026
- InspireMD Announces Proposed Public Offering, GlobeNewswire, November 12, 2026
- InspireMD Announces Pricing of $37.5 Million Public Offering, GlobeNewswire via The Manila Times, November 13, 2026
- Ainos Secures Largest Order in Company History: $9 Million ASE Agreement for 5,000 Additional AI Nose Systems, ACCESS Newswire via Stockhouse, November 12, 2026
- Ainos Signs $9M ASE Agreement for 5,000 AI Nose Systems, StockTitan, November 12, 2026
- Ainos, Inc. Form 10-Q for the Quarter Ended June 30, 2026, SEC EDGAR
- Tudor Gold Expands Footprint of Treaty Creek’s Perfectstorm Zone with Drill Results Intersecting High-Grade Gold, Newsfile Corp via StockTitan, November 11, 2026
- Tudor Gold Completes Metallurgy With the PEA Among 5 Open 2026 Goals, Crux Investor, 2026
- Tudor Gold Stock Quote and News, Junior Mining Network
- Turbo Energy Expands Pamesa Net Zero Contract with $7.6 Million in Additional Storage and Energy Management Orders, SEC EDGAR (Form 6-K, Exhibit 99.1), November 10, 2026
- Turbo Energy Form 6-K: Pamesa Net Zero Phase II Contract Expansion, SEC EDGAR, November 10, 2026
- Turbo Energy Brings 62.5 MWh of Intelligent Energy Storage Online Across Three Industrial Sites, GlobeNewswire via Energy Digital, October 2026
- Nasdaq Confirms Turbo Energy’s Compliance With Minimum Stockholders’ Equity Requirement, SEC EDGAR (Form 6-K, Exhibit 99.1), June 5, 2026
- Bitcoin Price Falls 14% in a Week to $65,000 as Weekend Selling Breaks Friday’s Low, Bitcoin Magazine, November 14, 2026
- Why Is Bitcoin Crashing This Week?, 24/7 Wall St., November 14, 2026
- Crypto Daily Market Report, November 12, 2026, KuCoin
Editorial Disclosure
The Crypto & Fintech item in this article covers sector-wide activity; no specific company is the subject of coverage. Tickers discussed as company subjects in this article: NSPR (InspireMD), AIMD (Ainos), TUD / TDRRF (Tudor Gold), and TURB (Turbo Energy). aktiego.com has received no compensation from any company, IR firm, or third party in connection with this coverage, and no aktiego.com staff member holds a position in any security named above. Press release dates and primary sources were verified against SEC EDGAR, GlobeNewswire, ACCESS Newswire, and Newsfile Corp. All companies named as subjects are under $500 million USD in market capitalization as of the dates referenced above. InspireMD’s offering documents disclose substantial doubt about its ability to continue as a going concern; the company received a Nasdaq minimum bid price deficiency notice on July 17, 2026 and has until January 13, 2027 to regain compliance; its $37.5 million underwritten offering of shares, pre-funded warrants, and common warrants, priced the day after the FDA approval announcement, is substantially dilutive to existing shareholders; the CGuard Prime TCAR approval rests on a 50-patient, single-arm trial reporting 30-day outcomes; the company conducted a voluntary US recall of its CGuard Prime 135 cm delivery system in May 2026; and its SwitchGuard neuroprotection system is investigational and not available for sale in the US. Ainos discloses substantial doubt about its ability to continue as a going concern, reported $1.42 million in cash as of June 30, 2026 with minimal revenue, depends heavily on a single customer whose affiliate is also a lender to the company, and has not yet received the $4.5 million deposit or disclosed a delivery schedule for the ASE order. Tudor Gold is an exploration-stage company with no revenue; its US listing, TDRRF, is quoted on OTC Pink, a limited-disclosure tier, and US investors should confirm availability with their broker; drill results are reported as drilled lengths, true widths have not been determined, select surface samples may not represent true grades, the Perfectstorm Zone has no mineral resource estimate under NI 43-101 (National Instrument 43-101, Canada’s disclosure standard for mineral projects), and the Goldstorm PEA has not been published. Turbo Energy’s Phase II orders are contracted bookings with equipment deliveries expected in the first half of 2027, remain subject to their contract terms, and are concentrated in a single industrial customer group; the company received a Nasdaq stockholders’ equity deficiency notice in January 2026, regained compliance in June 2026 after equity raises including an at-the-market program, and Nasdaq stated it may be subject to delisting if its next periodic report fails to evidence compliance. These are speculative investments carrying significant risk including potential total loss of capital. Digital assets are highly volatile. Coverage on aktiego.com is provided for informational and educational purposes only, aktiego.com is not a registered investment advisor, and nothing in this article constitutes financial, investment, or professional advice. Readers are encouraged to conduct their own due diligence and consult a qualified financial advisor before making any investment decisions. For more information please see our full DISCLAIMER.











